These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 15899889)
1. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. Chiang GG; Abraham RT J Biol Chem; 2005 Jul; 280(27):25485-90. PubMed ID: 15899889 [TBL] [Abstract][Full Text] [Related]
2. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells. Ahmed M; Kundu GC Mol Cancer; 2010 May; 9():101. PubMed ID: 20459645 [TBL] [Abstract][Full Text] [Related]
3. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051 [TBL] [Abstract][Full Text] [Related]
4. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463 [TBL] [Abstract][Full Text] [Related]
5. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. Byfield MP; Murray JT; Backer JM J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009 [TBL] [Abstract][Full Text] [Related]
6. Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors. Melick CH; Jewell JL Biochem J; 2020 May; 477(10):1847-1863. PubMed ID: 32347294 [TBL] [Abstract][Full Text] [Related]
7. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB. Varma S; Khandelwal RL Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420 [TBL] [Abstract][Full Text] [Related]
8. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
9. Determinants of rapamycin sensitivity in breast cancer cells. Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980 [TBL] [Abstract][Full Text] [Related]
10. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Khamzina L; Veilleux A; Bergeron S; Marette A Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215 [TBL] [Abstract][Full Text] [Related]
11. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. Bishop JD; Nien WL; Dauphinee SM; Too CK J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564 [TBL] [Abstract][Full Text] [Related]
12. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. Holz MK; Blenis J J Biol Chem; 2005 Jul; 280(28):26089-93. PubMed ID: 15905173 [TBL] [Abstract][Full Text] [Related]
13. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. Hresko RC; Mueckler M J Biol Chem; 2005 Dec; 280(49):40406-16. PubMed ID: 16221682 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641 [TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR. Wang L; Lawrence JC; Sturgill TW; Harris TE J Biol Chem; 2009 May; 284(22):14693-7. PubMed ID: 19346248 [TBL] [Abstract][Full Text] [Related]
16. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain. Yu J; Henske EP Cancer Res; 2006 Oct; 66(19):9461-6. PubMed ID: 17018601 [TBL] [Abstract][Full Text] [Related]
17. The mammalian target of rapamycin-p70 ribosomal S6 kinase but not phosphatidylinositol 3-kinase-Akt signaling is responsible for fibroblast growth factor-9-induced cell proliferation. Wing LY; Chen HM; Chuang PC; Wu MH; Tsai SJ J Biol Chem; 2005 May; 280(20):19937-47. PubMed ID: 15760907 [TBL] [Abstract][Full Text] [Related]
18. S6K1 plays a key role in glial transformation. Nakamura JL; Garcia E; Pieper RO Cancer Res; 2008 Aug; 68(16):6516-23. PubMed ID: 18701474 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid. Avila-Flores A; Santos T; Rincón E; Mérida I J Biol Chem; 2005 Mar; 280(11):10091-9. PubMed ID: 15632115 [TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Cao X; Kambe F; Moeller LC; Refetoff S; Seo H Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]